Retroviral vectors directed to predefined cell types for gene therapy

Biologicals

Volumn 23, Issue 1, 1995, Pages 5-12

  Günzburg, Walter H ^a   Saller, Robert M ^a   Salmons, Brian ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS ENVELOPE;

ANIMAL; FORECASTING; GENE THERAPY; HUMAN; RETROVIRIDAE; SUPPORT, NON-U.S. GOV'T; TROPISM;

UNIDENTIFIED RETROVIRUS;

EID: 0028937811     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/1045-1056(95)90003-9     Document Type: Article

References (41)

1. Improved methods of retroviral vector transduction and production for gene therapy
2. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumorinfiltrating lymphocytes modified by retroviral gene transduction
3. Human gene therapy
4. Retroviruses
5. Targeting of retroviral vectors for gene therapy
6. Safety of genetically engineered retroviruses used for gene transfer
7. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
8. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
9. Cellular receptors and viral glycoproteins involved in retrovirus entry
10. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity
11. Retroviral vectors displaying functional antibody fragments
12. Antibody-mediated binding of a murine ecotropic moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state
13. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virusderived viruses
14. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker
15. Packaging system for rapid production of murine leukemia virus vectors with variable tropism
16. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
17. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
18. Unerwartete transgene Expression eines gesaeugespeifischen Wachstumshormon Genkonstruktes in den Bergmann-Gliazellen der Maus
19. A mammary-specific promoter directs expression of growth hormone not only to the mammary gland but also to Bergman glia cells in transgenic mice
20. A negative regulatory element in the mammary specific whey acidic protein promoter
21. Lineage analysis in the vertebrate nervous system by retrovras-mediated gene transfer
22. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
23. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors
24. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase
25. Retroviralmediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy
26. Current perspectives in the biology of mouse mammary tumour virus
27. Factors controlling the expression of mouse mammary tumour virus
28. Mouse mammary tumour virus mediated transfer and expression of neomycin resistance to infected cultured cells
29. naf, a trans- regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region
30. Conditional expression of human TNF-a: a system for inducible cytotoxicity
31. Construction and characterization of a packaging cell line for MMTV based retroviral vectors
32. Subversion of host immune responses by viral superantigens
33. Negative acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat
34. Endogenous superantigen expression controlled by a novel pro moter in the MMTV long terminal repeat
35. On the generation of endogenous superantigen diversity
36. Activator dependent and activator independent defective recombinant retroviruses from bovine leukemia virus
37. Altering the genome by homologous recombination
38. Modifying the mouse: design and desire
39. Gene targeting in mammalian cells by homologous recombination
40. Gene targeting with retroviral vectors recombination by gene conversion into regions of nonhomology
41. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters